Download Free Sample Report

The global H1N1 Vaccines market was valued at US$ 4708.9 million in 2022 and is projected to reach US$ 5797.1 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
This report aims to provide a comprehensive presentation of the global market for H1N1 Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding H1N1 Vaccines. This report contains market size and forecasts of H1N1 Vaccines in global, including the following market information:

• Global H1N1 Vaccines Market Revenue, 2018-2023, 2024-2032, ($ millions)
• Global H1N1 Vaccines Market Sales, 2018-2023, 2024-2032, (K Units)
• Global top five H1N1 Vaccines companies in 2022 (%)

The global H1N1 vaccination market is anticipated to boost in the focus period due to the rising cases of swine flu. Additionally, the rising geriatric population increases the risk of respiratory tract diseases, and immune deficient diseases, thus increasing the risk factor for acquiring H1N1 influenza. Moreover, increased research in the field of vaccine technologies and significant government support are driving this market. However, lack of awareness and absence of experienced medical professionals are restraining the growth of H1N1 vaccines market. Furthermore, high capital requirement and stringent regulations are also hindering the growth of the global H1N1 vaccination market.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the H1N1 Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global H1N1 Vaccines Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global H1N1 Vaccines Market Segment Percentages, by Type, 2022 (%)

• Intramuscular Vaccines
• Intranasal Vaccines
• Intradermal Vaccines

Global H1N1 Vaccines Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global H1N1 Vaccines Market Segment Percentages, by Application, 2022 (%)

• Influenza
• Meningococcal
• Cervical Cancer
• Pneumococcal
• Hepatitis
• Measles
• Mumps
• Rubella
• Others

Global H1N1 Vaccines Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global H1N1 Vaccines Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies H1N1 Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies H1N1 Vaccines revenues share in global market, 2022 (%)
Key companies H1N1 Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies H1N1 Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Baxter International
• Sanofi
• GSK
• Pfizer
• Mitsubishi Tanabe Pharma
• Hualan Biological Engineering
• Cipla
• Merck
• Sinovac Biotech

Outline of Major Chapters:

• Chapter 1: Introduces the definition of H1N1 Vaccines, market overview.
• Chapter 2: Global H1N1 Vaccines market size in revenue and volume.
• Chapter 3: Detailed analysis of H1N1 Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of H1N1 Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global H1N1 Vaccines capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.